Biomx Ltd is a biotechnology company focused on developing innovative therapies that harness the power of bacteriophage, a type of virus that specifically targets and kills bacteria

The company primarily aims to treat diseases caused by specific bacterial infections, particularly those that are resistant to traditional antibiotics. By utilizing phage-based treatments, Biomx is working to address significant medical challenges in various conditions, including gastrointestinal disorders and other diseases driven by harmful bacteria, with the ultimate goal of improving patient outcomes and enhancing the overall landscape of antimicrobial therapies.